# 2026年1月5日 - 专业文献速递

本期速递为您整理了最新的科研文献及AI评价，每一篇文献都包含了详细的元数据、原文摘要、中文翻译和AI的专业点评，敬请参考。

---

## 1. 协作交叉小鼠的遗传多样性揭示 FFAR3 是 ILC2 抗炎重塑的靶标。

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41484153)
**期刊：** Nature communications
**PMID：** 41484153
**DOI：** 10.1038/s41467-025-67813-2

### 第一部分 原文与翻译

**英文原标题：** Genetic diversity of Collaborative Cross mice implicates FFAR3 as a target for ILC2 anti-inflammatory reprogramming.

> **英文摘要：**
> Pulmonary group 2 innate lymphoid cells (ILC2s) are key drivers of Type 2 inflammation in diseases like asthma, yet the molecular mechanisms regulating their function are incompletely understood. Using the genetically diverse Collaborative Cross (CC) mouse panel, we mapped a quantitative trait locus (QTL) that governs ILC2 prevalence in the lung after aeroallergen exposure. This QTL induces a large population of ILC2s in the lung that are resistant to activation and have diminished Type 2 effector function. We identified free-fatty acid receptor 3 (Ffar3) as a gene responsible for this effect and demonstrated that FFAR3 signaling reprograms ILC2s to an anti-inflammatory state by promoting their survival, reducing Type 2 cytokine production, and enhancing IL-10 expression. This anti-inflammatory state is dependent on IL-2 signaling, is characterized by decreased ST2 expression, and is distinct from previously described IL-10-producing ILC2 phenotypes. FFAR3-dependent reprogramming is mediated by epidermal growth factor receptor (EGFR) upregulation, and FFAR3's anti-inflammatory effect is partially conserved in human ILC2s.

> **中文摘要：**
> 肺部第二型先天性淋巴细胞（ILC2）是哮喘等疾病中 2 型炎症的主要驱动因素，但调控其功能的分子机制尚未完全明了。利用具有遗传多样性的协作交叉（Collaborative Cross, CC）小鼠资源群，我们绘制了一个在气道过敏原暴露后调控肺部 ILC2 数量的数量性状位点（QTL）。该 QTL 可诱导肺中形成大量对激活具有抗性、且 2 型效应功能减弱的 ILC2。我们鉴定出游离脂肪酸受体 3（free-fatty acid receptor 3，Ffar3）是导致该效应的关键基因，并进一步证明 FFAR3 信号通过促进 ILC2 存活、降低 2 型细胞因子产生并增强 IL-10 表达，从而将 ILC2 重编程为抗炎状态。该抗炎状态依赖于 IL-2 信号传导，其特征为 ST2 表达下降，并与先前报道的 IL-10 产生型 ILC2 表型不同。FFAR3 依赖性重编程由表皮生长因子受体（EGFR）上调介导，而 FFAR3 的抗炎效应在人源 ILC2 中亦部分保守存在。

### 第二部分 AI 大师评价

本研究利用协作交叉小鼠的遗传多样性揭示了 FFAR3 在调控 ILC2 抗炎重塑中的关键作用。研究通过 QTL 定位发现 FFAR3 影响 ILC2 的数量与功能，并阐明其通过促存活、减弱 2 型炎症及增强 IL-10 表达的机制。论文进一步指出该过程依赖 IL-2 信号并涉及 EGFR 上调，为调控 ILC2 免疫反应提供了新靶点。研究创新性地将代谢受体 FFAR3 与 ILC2 功能重编程相联系，但在人类系统中的保守性尚需进一步验证。

---

## 2. 1990–2023年间204个国家和地区女性亲密伴侣暴力与儿童性暴力所致疾病负担：全球疾病负担研究2023的系统分析

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41386261)
**期刊：** Lancet (London, England)
**PMID：** 41386261
**DOI：** 10.1016/S0140-6736(25)02503-6

### 第一部分 原文与翻译

**英文原标题：** Disease burden attributable to intimate partner violence against females and sexual violence against children in 204 countries and territories, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.

> **英文摘要：**
> BACKGROUND: Violence against women and against children are human rights violations with lasting harms to survivors and societies at large. Intimate partner violence (IPV) and sexual violence against children (SVAC) are two major forms of such abuse. Despite their wide-reaching effects on individual and community health, these risk factors have not been adequately prioritised as key drivers of global health burden. Comprehensive x§and reliable estimates of the comparative health burden of IPV and SVAC are urgently needed to inform investments in prevention and support for survivors at both national and global levels.
> 
> METHODS: We estimated the prevalence and attributable burden of IPV among females and SVAC among males and females for 204 countries and territories, by age and sex, from 1990 to 2023, as part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2023. We searched several global databases for data on self-reported exposure to IPV and SVAC and undertook a systematic review to identify the health outcomes associated with each of these risk factors. We modelled IPV and SVAC prevalence using spatiotemporal Gaussian process regression, applying data adjustments to account for measurement heterogeneity. We employed burden-of-proof methodology to estimate relative risks for outcomes associated with IPV and SVAC. These estimates informed the calculation of population attributable fractions, which were then used to quantify disability-adjusted life-years (DALYs) attributable to each risk factor.
> 
> FINDINGS: Globally, in 2023, we estimated that 608 million (95% uncertainty interval 518-724) females aged 15 years and older had ever been exposed to IPV, and 1·01 billion (0·764-1·48) individuals aged 15 years and older had experienced sexual violence during childhood. 18·5 million (8·74-30·0) DALYs were attributed to IPV among females and 32·2 million (16·4-52·5) DALYs were attributed to SVAC among males and females in 2023. IPV and SVAC were among the top contributors to the global disease burden in 2023, particularly among females aged 15-49 years, ranking as the fourth and fifth leading risk factors, respectively, for DALYs in this group. Among the eight health outcomes found to be associated with IPV, anxiety disorders and major depressive disorder were the leading causes of IPV-attributed DALYs, accounting for 5·43 million (-1·25 to 14·6) and 3·96 million (1·71 to 6·92) DALYs in 2023, respectively. SVAC was associated with 14 health outcomes, including mental health disorder, substance use disorder, and chronic and infectious disease outcomes. Self-harm and schizophrenia were the leading causes of SVAC-attributed burden, with SVAC accounting for 6·71 million (2·00 to 12·7) DALYs due to self-harm and 4·15 million (-1·92 to 13·1) DALYs due to schizophrenia in 2023.
> 
> INTERPRETATION: IPV and SVAC are substantial contributors to global health burden, and their health consequences span a variety of individual health outcomes. Importantly, mental health disorders account for the greatest share of disease burden among survivors. Investing in prevention of these avoidable risk factors has the potential to avert millions of DALYs and considerable premature mortality each year. Our findings represent strong evidence for global and national leaders to elevate IPV and SVAC among public health priorities. Sustained investments are needed to prevent IPV and SVAC and to implement interventions focused on supporting the complex social and health needs of survivors.
> 
> FUNDING: Gates Foundation.

> **中文摘要：**
> 背景：针对女性和儿童的暴力是侵犯人权的行为，会对幸存者及整个社会造成持久危害。亲密伴侣暴力（IPV）和针对儿童的性暴力（SVAC）是此类虐待的两种主要形式。尽管它们对个体及社区健康有广泛影响，但作为全球健康负担的关键驱动因素，这些风险因素尚未得到足够重视。迫切需要全面且可靠的估算，以比较IPV与SVAC所致健康负担，从而为国家和全球层面的预防投入及幸存者支持提供依据。
> 
> 方法：作为全球疾病、伤害与风险因素研究2023（GBD 2023）的一部分，我们估算了1990至2023年间，按年龄和性别划分的204个国家和地区女性的IPV患病率及其归因负担，以及男女儿童的SVAC患病率及其归因负担。我们检索了多个全球数据库，收集关于自我报告的IPV和SVAC暴露数据，并系统回顾识别了与每种风险因素相关的健康结局。采用时空高斯过程回归方法对IPV和SVAC的流行率进行建模，并通过数据调整处理测量异质性。我们运用“举证责任”（burden-of-proof）方法估计了IPV及SVAC相关结局的相对风险。这些估算值用于计算人群归因分值（PAF），进而用于估算每种风险因素所致的伤残调整生命年（DALY）。
> 
> 结果：在2023年，全球估计有6.08亿（95%不确定区间：5.18–7.24亿）名15岁及以上女性曾遭受过IPV，另有约10.1亿（0.764–1.48亿）名15岁及以上个体在童年时期经历过性暴力。2023年，女性IPV所致DALY为1,850万（874–3,000万），男性和女性儿童SVAC相关DALY为3,220万（1,640–5,250万）。IPV和SVAC是2023年全球疾病负担的主要贡献因素之一，尤其在15至49岁女性中，分别位列该年龄组DALY的第四与第五位风险因素。在与IPV相关的八种健康结局中，焦虑障碍和重度抑郁障碍是IPV相关DALY的主要来源，分别占2023年5.43百万（-1.25至14.6百万）和3.96百万（1.71至6.92百万）DALY。SVAC与14种健康结局相关，包括心理障碍、物质使用障碍以及慢性与感染性疾病结局。其中自我伤害和精神分裂症是SVAC相关负担的首要原因，SVAC导致的自我伤害DALY为6.71百万（2.00至12.7百万），精神分裂症为4.15百万（-1.92至13.1百万）。
> 
> 解释：IPV和SVAC是全球健康负担的重要组成部分，其健康后果涵盖多种个体健康结局。值得注意的是，心理健康障碍在幸存者总体疾病负担中占比最大。预防这些可避免的风险因素有潜力每年挽救数百万DALY并减少过早死亡。本研究结果为全球和国家层面将IPV与SVAC提升至公共卫生优先事项提供了有力证据。应持续投入预防IPV与SVAC，并实施旨在支持幸存者社会和健康需求的综合干预措施。
> 
> 资金来源：盖茨基金会。

### 第二部分 AI 大师评价

本研究系统评估了1990至2023年间204个国家和地区中，女性亲密伴侣暴力及儿童性暴力的全球疾病负担，基于GBD 2023数据库，使用时空建模与风险归因方法量化其健康影响。结果显示，IPV与SVAC均对全球DALY构成显著贡献，尤其影响15–49岁女性群体。研究凸显心理健康障碍是主要负担来源，并建议加强预防与干预投入。其创新在于首次比较两类性别暴力对全球疾病负担的相对影响，但其估算仍受自报数据及测量异质性限制。

---

速递结束，祝您工作愉快！